CoChat

Ursodeoxycholic acid inhibits interleukin beta 1 and deoxycholic acid‐induced activation of NF‐κB and AP‐1 in human colon cancer cells

Open access
Shah, Syed A., Volkov, Yuri, Arfin, Qamrul, Abdel‐Latif, Mohamed M., Kelleher, Dermot · 2006 · International Journal of Cancer
Cited by 84

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Deoxycholic acid (DCA) has been implicated in colorectal carcinogenesis in humans with effects on proliferation and apoptosis, mediated at least in part by activation of transcription factors nuclear factor kappa B (NF‐κB), activator protein 1 (AP‐1) and protein kinase C (PKC) enzymes. Ursodeoxycholic acid (UDCA) is reported to reduce the frequency of colonic carcinogenesis in ulcerative colitis patients. Hence, we postulated that it might differ from DCA in its regulation of these transcription factors. The aim of the study was to determine effects of DCA and UDCA on NF‐κB and AP‐1 activation and explore its relationship to PKC. Human colonic tumour cell lines HCT116 were treated with DCA, UDCA, alone or pretreated with UDCA followed by DCA or IL‐1β. In other experiments, cells were pretreated with PKC inhibitors and then stimulated with DCA and IL‐1β or PMA. Gel shift assays were performed on nuclear extracts of the cells for NF‐κB and AP‐1 analysis. Western blot analyses and immunofluorescence were performed for Rel A (p65) and IκB‐α levels on the treated cells. DCA increased NF‐κB and AP‐1 DNA binding. UDCA did not increase DNA binding of NF‐κB and AP‐1 and UDCA pretreatment inhibited DCA‐induced NF‐κB and AP‐1 DNA binding. PKC inhibitors blocked DCA‐induced NF‐κB and AP‐1 activation. These results were validated by Western blot analysis for RelA and IκB‐α. In conclusion, UDCA did not induce NF‐κB and AP‐1 DNA binding but also blocked DCA‐induced NF‐κB and AP‐1 activation. These findings suggest a possible mechanistic role for UDCA in blocking pathways thought to be involved in colon carcinogenesis. © 2005 Wiley‐Liss, Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ijc.21365

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 84

Metadata

Authors
Shah, S. A., Volkov, Y., Arfin, Q., Abdel‐Latif, M. M., & Kelleher, D.
Venue
International Journal of Cancer
Publisher
Wiley
Published
2005-11-29
Volume
118
Issue
3
Pages
532-539
ISSN
  • 0020-7136 (ISSN-L)
  • 1097-0215
OpenAlex
W2130973485
Cited by
84
References
1
FWCI
0.96
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Ursodeoxycholic acid inhibits interleukin beta 1 and deoxycholic acid‐induced activation of NF‐κB and AP‐1 in human colon cancer cells. https://app.cochat.ai/papers/10.1002/ijc.21365
The paper
Shah, S. A., Volkov, Y., Arfin, Q., Abdel‐Latif, M. M., & Kelleher, D. (2006). Ursodeoxycholic acid inhibits interleukin beta 1 and deoxycholic acid‐induced activation of NF‐κB and AP‐1 in human colon cancer cells. International Journal of Cancer. https://doi.org/10.1002/ijc.21365

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.